[1]
Y. R. Nusantoro and A. Fadlan, “In silico studies of isatinyl-2-aminobenzoylhydrazone transition metal complexes against cyclin-dependent kinase 6 (CDK6)”, Pharm.Rep., vol. 1, no. 1, p. 4, Aug. 2021.